Ismail Cimen1, Zehra Yildirim2, Asli Ekin Dogan2, Asli Dilber Yildirim2, Ozlem Tufanli3, Umut Inci Onat4, UyenThao Nguyen5, Steven M Watkins6, Christian Weber7, Ebru Erbay8. 1. Institute for Cardiovascular Prevention, LMU Munich, German Cardiovascular Research Centre (DZHK), Partner Site Munich Heart Alliance Munich, 80336, Germany. 2. Department of Molecular Biology and Genetics, Bilkent University, Ankara, 06800, Turkey; National Nanotechnology Center, Bilkent University, Ankara, 06800, Turkey; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. 3. New York University, Lagone Medical Center, New York, NY 10016, USA. 4. Department of Molecular Biology and Genetics, Bilkent University, Ankara, 06800, Turkey; National Nanotechnology Center, Bilkent University, Ankara, 06800, Turkey. 5. Metabolon, Morrisville, NC, 27560, USA. 6. Verso Biosciences, San Francisco, CA, 94124, USA. 7. Institute for Cardiovascular Prevention, LMU Munich, German Cardiovascular Research Centre (DZHK), Partner Site Munich Heart Alliance Munich, 80336, Germany; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands. 8. Department of Molecular Biology and Genetics, Bilkent University, Ankara, 06800, Turkey; National Nanotechnology Center, Bilkent University, Ankara, 06800, Turkey; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. Electronic address: ebru.erbay@cshs.org.
Abstract
OBJECTIVE: Saturated and trans fat consumption is associated with increased cardiovascular disease (CVD) risk. Current dietary guidelines recommend low fat and significantly reduced trans fat intake. Full fat dairy can worsen dyslipidemia, but recent epidemiological studies show full-fat dairy consumption may reduce diabetes and CVD risk. This dairy paradox prompted a reassessment of the dietary guidelines. The beneficial metabolic effects in dairy have been claimed for a ruminant-derived, trans fatty acid, trans-C16:1n-7 or trans-palmitoleate (trans-PAO). A close relative, cis-PAO, is produced by de novo lipogenesis and mediates inter-organ crosstalk, improving insulin-sensitivity and alleviating atherosclerosis in mice. These findings suggest trans-PAO may be a useful substitute for full fat dairy, but a metabolic function for trans-PAO has not been shown to date. METHODS: Using lipidomics, we directly investigated trans-PAO's impact on plasma and tissue lipid profiles in a hypercholesterolemic atherosclerosis mouse model. Furthermore, we investigated trans-PAO's impact on hyperlipidemia-induced inflammation and atherosclerosis progression in these mice. RESULTS: Oral trans-PAO supplementation led to significant incorporation of trans-PAO into major lipid species in plasma and tissues. Unlike cis-PAO, however, trans-PAO did not prevent organelle stress and inflammation in macrophages or atherosclerosis progression in mice. CONCLUSIONS: A significant, inverse correlation between circulating trans-PAO levels and diabetes incidence and cardiovascular mortality has been reported. Our findings show that trans-PAO can incorporate efficiently into the same pools that its cis counterpart is known to incorporate into. However, we found trans-PAO's anti-inflammatory and anti-atherosclerotic effects are muted due to its different structure from cis-PAO.
OBJECTIVE: Saturated and trans fat consumption is associated with increased cardiovascular disease (CVD) risk. Current dietary guidelines recommend low fat and significantly reduced trans fat intake. Full fat dairy can worsen dyslipidemia, but recent epidemiological studies show full-fat dairy consumption may reduce diabetes and CVD risk. This dairy paradox prompted a reassessment of the dietary guidelines. The beneficial metabolic effects in dairy have been claimed for a ruminant-derived, trans fatty acid, trans-C16:1n-7 or trans-palmitoleate (trans-PAO). A close relative, cis-PAO, is produced by de novo lipogenesis and mediates inter-organ crosstalk, improving insulin-sensitivity and alleviating atherosclerosis in mice. These findings suggest trans-PAO may be a useful substitute for full fat dairy, but a metabolic function for trans-PAO has not been shown to date. METHODS: Using lipidomics, we directly investigated trans-PAO's impact on plasma and tissue lipid profiles in a hypercholesterolemic atherosclerosismouse model. Furthermore, we investigated trans-PAO's impact on hyperlipidemia-induced inflammation and atherosclerosis progression in these mice. RESULTS: Oral trans-PAO supplementation led to significant incorporation of trans-PAO into major lipid species in plasma and tissues. Unlike cis-PAO, however, trans-PAO did not prevent organelle stress and inflammation in macrophages or atherosclerosis progression in mice. CONCLUSIONS: A significant, inverse correlation between circulating trans-PAO levels and diabetes incidence and cardiovascular mortality has been reported. Our findings show that trans-PAO can incorporate efficiently into the same pools that its cis counterpart is known to incorporate into. However, we found trans-PAO's anti-inflammatory and anti-atherosclerotic effects are muted due to its different structure from cis-PAO.
Authors: Haiming Cao; Kristin Gerhold; Jared R Mayers; Michelle M Wiest; Steven M Watkins; Gökhan S Hotamisligil Journal: Cell Date: 2008-09-19 Impact factor: 41.582
Authors: Ozlem Tufanli; Pelin Telkoparan Akillilar; Diego Acosta-Alvear; Begum Kocaturk; Umut Inci Onat; Syed Muhammad Hamid; Ismail Çimen; Peter Walter; Christian Weber; Ebru Erbay Journal: Proc Natl Acad Sci U S A Date: 2017-01-30 Impact factor: 11.205
Authors: W C Willett; M J Stampfer; J E Manson; G A Colditz; F E Speizer; B A Rosner; L A Sampson; C H Hennekens Journal: Lancet Date: 1993-03-06 Impact factor: 79.321
Authors: Amanda C Doran; Lale Ozcan; Bishuang Cai; Ze Zheng; Gabrielle Fredman; Christina C Rymond; Bernhard Dorweiler; Judith C Sluimer; Joanne Hsieh; George Kuriakose; Alan R Tall; Ira Tabas Journal: J Clin Invest Date: 2017-10-03 Impact factor: 14.808
Authors: Mohammad Y Yakoob; Peilin Shi; Walter C Willett; Kathryn M Rexrode; Hannia Campos; E John Orav; Frank B Hu; Dariush Mozaffarian Journal: Circulation Date: 2016-03-22 Impact factor: 29.690
Authors: Jeu Park; Jee Hyung Sohn; Sang Mun Han; Yoon Jeong Park; Jin Young Huh; Sung Sik Choe; Jae Bum Kim Journal: Front Immunol Date: 2021-01-28 Impact factor: 7.561
Authors: Miguel A Bermúdez; Laura Pereira; Cristina Fraile; Laura Valerio; María A Balboa; Jesús Balsinde Journal: Cells Date: 2022-07-08 Impact factor: 7.666
Authors: Rudolf Poledne; Hana Malinska; Hana Kubatova; Jiri Fronek; Filip Thieme; Sona Kauerova; Ivana Kralova Lesna Journal: Nutrients Date: 2019-12-18 Impact factor: 5.717